---
title: "Akanda soars 21% as healthcare stocks rally"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284906278.md"
description: "Akanda（AKAN.US）现价 $59.38，当日 +21.28%，5 分钟涨幅超 3%，市值 0.29 亿。公司主营医疗保健，近期盘中短线大涨，叠加医疗板块整体波动。当前无重大公告，异动或与资金短线炒作和行业轮动有关。"
datetime: "2026-05-01T13:55:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284906278.md)
  - [en](https://longbridge.com/en/news/284906278.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284906278.md)
---

# Akanda soars 21% as healthcare stocks rally

Akanda (AKAN.US) is trading at $59.38, up **21.28%** intraday with a 5-minute gain over 3%, market cap $29 million.

The healthcare-focused company surged during a period of volatility across the sector, alongside other medical stocks. No major news has been reported; the move may relate to speculative trading and sector rotation.

### Related Stocks

- [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [Akanda Corp. Delays 20-F Amid Strategic Shift](https://longbridge.com/en/news/284929092.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Precigen Q1 revenue beats estimates on PAPZIMEOS launch](https://longbridge.com/en/news/286311056.md)
- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)